Your browser doesn't support javascript.
loading
PP1 catalytic isoforms are differentially expressed and regulated in human prostate cancer.
Felgueiras, Juliana; Lobo, João; Camilo, Vânia; Carneiro, Isa; Matos, Bárbara; Henrique, Rui; Jerónimo, Carmen; Fardilha, Margarida.
  • Felgueiras J; Laboratory of Signal Transduction, Department of Medical Sciences, Institute of Biomedicine - iBiMED, University of Aveiro, Aveiro, Portugal; Cancer Biology and Epigenetics Group - Research Center, Portuguese Oncology Institute of Porto, Porto, Portugal & Porto Comprehensive Cancer Center (P.CCC
  • Lobo J; Cancer Biology and Epigenetics Group - Research Center, Portuguese Oncology Institute of Porto, Porto, Portugal & Porto Comprehensive Cancer Center (P.CCC), Portugal; Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal; Department of Pathology and Molecular Immunolog
  • Camilo V; Cancer Biology and Epigenetics Group - Research Center, Portuguese Oncology Institute of Porto, Porto, Portugal & Porto Comprehensive Cancer Center (P.CCC), Portugal.
  • Carneiro I; Cancer Biology and Epigenetics Group - Research Center, Portuguese Oncology Institute of Porto, Porto, Portugal & Porto Comprehensive Cancer Center (P.CCC), Portugal; Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal.
  • Matos B; Laboratory of Signal Transduction, Department of Medical Sciences, Institute of Biomedicine - iBiMED, University of Aveiro, Aveiro, Portugal; Cancer Biology and Epigenetics Group - Research Center, Portuguese Oncology Institute of Porto, Porto, Portugal & Porto Comprehensive Cancer Center (P.CCC
  • Henrique R; Cancer Biology and Epigenetics Group - Research Center, Portuguese Oncology Institute of Porto, Porto, Portugal & Porto Comprehensive Cancer Center (P.CCC), Portugal; Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal; Department of Pathology and Molecular Immunolog
  • Jerónimo C; Cancer Biology and Epigenetics Group - Research Center, Portuguese Oncology Institute of Porto, Porto, Portugal & Porto Comprehensive Cancer Center (P.CCC), Portugal; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Port
  • Fardilha M; Laboratory of Signal Transduction, Department of Medical Sciences, Institute of Biomedicine - iBiMED, University of Aveiro, Aveiro, Portugal. Electronic address: mfardilha@ua.pt.
Exp Cell Res ; 418(2): 113282, 2022 09 15.
Article en En | MEDLINE | ID: mdl-35841980

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Núcleo Celular Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Núcleo Celular Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Año: 2022 Tipo del documento: Article